Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) is -6.32% lower on its value in year-to-date trading and has touched a low of $1.74 and a high of $5.24 in the current 52-week trading range. The SPPI stock was last observed hovering at around $3.60 in the last trading session, with the day’s loss setting it -0.19% off its average median price target of $12.00 for the next 12 months. It is also 77.27% off the consensus price target high of $15.00 offered by 6 analysts, but current levels are 31.8% higher than the price target low of $5.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $3.41, the stock is -22.96% and -17.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.29 million and changing -5.28% at the moment leaves the stock -3.85% off its SMA200. SPPI registered -1.16% loss for a year compared to 6-month gain of -0.58%. The firm has a 50-day simple moving average (SMA 50) of $4.3906 and a 200-day simple moving average (SMA200) of $3.9017.
The stock witnessed a -26.19% loss in the last 1 month and extending the period to 3 months gives it a -18.23%, and is -11.77% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.19% over the week and 6.38% over the month.
Distance from 52-week low is 95.73% and -34.92% from its 52-week high.
Spectrum Pharmaceuticals Inc. (SPPI) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Spectrum Pharmaceuticals Inc. (SPPI) is a “Overweight”. 6 analysts offering their recommendations for the stock have an average rating of 2.20, where 2 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Spectrum Pharmaceuticals Inc. is expected to release its quarterly report on 05/13/2021 and quarterly earnings per share for the current quarter are estimated at -$0.29.The EPS is expected to grow by 0.20% this year.
Spectrum Pharmaceuticals Inc. (SPPI) Top Institutional Holders
236 institutions hold shares in Spectrum Pharmaceuticals Inc. (SPPI), with 2.21M shares held by insiders accounting for 1.53% while institutional investors hold 68.31% of the company’s shares. The shares outstanding are 145.92M, and float is at 134.53M with Short Float at 7.75%. Institutions hold 67.27% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 26.47 million shares valued at $107.99 million. The investor’s holdings represent 18.14% of the SPPI Shares outstanding. As of Sep 29, 2020, the second largest holder is Vanguard Group, Inc. (The) with 11.5 million shares valued at $46.91 million to account for 7.88% of the shares outstanding. The other top investors are Armistice Capital, LLC which holds 7.57 million shares representing 5.19% and valued at over $30.89 million, while State Street Corporation holds 4.71% of the shares totaling 6.88 million with a market value of $28.07 million.
Spectrum Pharmaceuticals Inc. (SPPI) Insider Activity
The most recent transaction is an insider sale by Turgeon Joseph W., the company’s CEO & President. SEC filings show that Turgeon Joseph W. sold 150,899 shares of the company’s common stock on Dec 16 at a price of $4.70 per share for a total of $0.71 million. Following the sale, the insider now owns 0.38 million shares.
Spectrum Pharmaceuticals Inc. disclosed in a document filed with the SEC on Dec 14 that GUSTAFSON KURT A (EVP & Chief Financial Officer) sold a total of 25,696 shares of the company’s common stock. The trade occurred on Dec 14 and was made at $5.00 per share for $0.13 million. Following the transaction, the insider now directly holds 0.34 million shares of the SPPI stock.
Still, SEC filings show that on Nov 18, Turgeon Joseph W. (CEO & President) disposed off 162,473 shares at an average price of $4.13 for $0.67 million. The insider now directly holds 528,661 shares of Spectrum Pharmaceuticals Inc. (SPPI).
Spectrum Pharmaceuticals Inc. (SPPI): Who are the competitors?
The company’s main competitors (and peers) include Biogen Inc. (BIIB) that is trading -17.48% down over the past 12 months. Bristol-Myers Squibb Company (BMY) is -2.07% down on the 1-year trading charts. Short interest in the company’s stock has fallen -10.35% from the last report on Nov 12, 2020 to stand at a total of 11.51 million short shares sold with a short interest ratio of 6.93.